PATENT CLAIM ANALYSIS

Application Number: 15903047
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["506", "009000"]

Abstract:
The invention relates to a method for diagnosis of colorectal carcinoma in a patient, including detecting, in a blood sample obtained from said patient, an indicator protein selected from integrin subunit alpha(v) and integrin subunit beta(6) or their heterodimer.

Claim (Index 7):
The method according to any one of  claim 5  or  6 , wherein said quantification step comprises the steps of contacting, in a second contacting step, said indicator protein with a second ligand specifically reactive to said indicator protein and determining an amount of said second ligand bound to said indicator protein.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.28947
- Patent Class: 506.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11822859', '11787044', '12452048', '11483190', '11886886']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5678651173487285
- 35 USC 102 Novelty (BERT): 0.5110295365579496
- Combined Prediction Score: 0.5621815592696506
- Mean Citation Score: 173.97337199999996
- Max Citation Score: 182.68294
- Similarity Product: 97.4303728659153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test